Logo image
Sign in
TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?
Journal article   Peer reviewed

TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?

Emmanuelle Samalin and Antoine Adenis
Lancet Oncology, Vol.21(8), pp.1002-1003
08/2020
PMID: 32682456

Abstract

Cisplatin Humans Leucovorin Oxaliplatin Stomach Neoplasms Tegafur
url
Find in HALView

Metrics

1 Record Views

Details

Logo image